Price Inflation Rebates And The Spectre Of 100% Discounts In Medicare Part D
Executive Summary
Medicaid programs are essentially getting Humira for free, in large part because of price inflation rebates, according to estimates by Bernstein analysts. Legislation pending in the US Senate wants to bring that dynamic to Medicare.
You may also be interested in...
Amgen Is Still ‘A Biotech At Heart’
Head of Amgen’s inflammation business, Kave Niksefat, gives insight into how the 40-year-old biotech maintains its culture of innovation and avoids falling into the “trap” of bureaucracy.
Insulin Report Revives Senate Finance Committee Push On Drug Pricing Legislation
Report released as soon-to-be committee chair Ron Wyden, D-OR, assembles plans for drug pricing legislation in the new Democratic-controlled Senate.
US Unemployment Looms As A Threat To Pharma, But More Impact In 2021
Sweeping job losses in the US have left people uninsured or transitioning from private insurance to Medicaid, which will impact how drugs are reimbursed. Changing payer mix will have an effect on company revenues.